Kala Pharmaceuticals Reports Third Quarter 2021 Financial Results and Provides Corporate Update
-- Achieved $3.1 Million in Net Revenue in 3Q 2021 ---- EYSUVIS® Prescriptions Increased by 19% Compared to 2Q 2021--...
News
Kala Pharmaceuticals Acquires Combangio, Expanding its Pipeline with a Clinical-Stage Novel Biologic for the Treatment of Persistent Corneal Epithelial Defect (PCED) and other Rare Ocular Surface Diseases
-- KPI-012 is a novel secretome with a multifactorial mechanism of action for development in PCED and other orphan ocular...
FDA Commences Review of Cell MedX’s Premarket Notification (510K) and Health Canada Renews Class II Medical Device Licenses for eBalance(R) Systems
Carson City, Nevada--(Newsfile Corp. - November 15, 2021) - Cell MedX Corp. (OTCQB: CMXC) ("Cell MedX" or the "Company"), a...
Red Light Holland Psilocybin Truffles, Sold in The Netherlands, Complete First Evaluation Under a Health Canada Approved cGMP Laboratory
Red Light Holland is continuing its groundbreaking working synergies with Shaman Pharma Corp. and their cGMP laboratory partner, CCrest Laboratories...
Netsmart and American Society of Addiction Medicine Announce Partnership to Integrate ASAM CONTINUUM System
OVERLAND PARK, Kan.--(BUSINESS WIRE)--#ASAM--Netsmart, an industry-leading provider of healthcare technology solutions and services, today announced a strategic partnership with the...
Pear Therapeutics Provides 2021 Business Update and Reaffirms Full Year 2021 Revenue Guidance
BOSTON--(BUSINESS WIRE)--Pear Therapeutics, Inc. (“Pear”), the leader in developing and commercializing software-based medicines, called prescription digital therapeutics (PDTs), today provides...
Abdul Latif Jameel Health and Butterfly Network enter strategic distribution partnership to bring Butterfly iQ+ ultrasound device to a potential 2 billion1 people across the Middle East, North Africa, Turkey & India
The Butterfly iQ+ is the world’s only single-probe, whole-body, handheld imaging device with the potential to bring medical imaging to...
InfuSystem Reports Third Quarter 2021 Financial Results
Selected as Supplier of Infusion Pump Biomedical Services for Leading Global Medical Technology and Diagnostic Equipment Company Worth Expected $14...
Biophytis Announces US Centers to Restart Recruitment for the COVA Phase 2-3 Study with Sarconeos (BIO101) in COVID-19
PARIS, FRANCE and CAMBRIDGE, MA / ACCESSWIRE / November 15, 2021 / Biophytis SA (NasdaqCM:BPTS, Euronext Growth Paris: ALBPS) (the...
Angle PLC Announces Appointment of Chief Medical Officer
Todd Druley, M.D., PhD. brings deep experience of building a medical team and establishing oncology assays, most recently at ArcherDX,...
New Study Finds That Use of Masimo SedLine® PSi and DSA May Significantly Reduce Postoperative Delirium
NEUCHATEL, Switzerland--(BUSINESS WIRE)--Masimo (NASDAQ: MASI) today announced the findings of a prospective study published in Frontiers in Neurology in which...
Lexicon’s Sotagliflozin Demonstrates Benefits in Heart Failure and Blood Glucose Control Across the Full Range of Kidney Function in New Analysis of Clinical Data
Post hoc analysis of pooled clinical data from the SOLOIST and SCORED trials supporting benefit of sotagliflozin presented at the...
Philips provides update on earlier announced voluntary CPAP, BiPAP and Mechanical Ventilator recall notification*
November 14, 2021 Amsterdam, the Netherlands – On June 14, 2021, Royal Philips’ (NYSE: PHG, AEX: PHIA) subsidiary, Philips Respironics,...
Iovance Biotherapeutics Announces Clinical Data for Lifileucel in Combination with Pembrolizumab in Advanced Cancers at Society for Immunotherapy of Cancer (SITC) Annual Meeting
Tumor Infiltrating Lymphocyte (TIL) Cell Therapy in Combination with Pembrolizumab in Immune-Checkpoint Inhibitor Naïve Patients Shows Overall Response Rate (ORR)...
NextCure and Collaborators Provide Clinical and Research Updates on NC318 and NC410 Candidates at Society for Immunotherapy of Cancer Annual Meeting
BELTSVILLE, Md., Nov. 13, 2021 (GLOBE NEWSWIRE) -- NextCure, Inc. (Nasdaq: NXTC), a clinical-stage biopharmaceutical company committed to discovering and developing...
Aadi Bioscience Presents Two Abstracts on FYARRO (nab-Sirolimus) at the Annual Meeting of the Connective Tissue Oncology Society (CTOS)
In an Expanded Access Program, advanced malignant PEComa patients who previously progressed on other mTOR inhibitors showed a 25% partial response rate...
Outlook Therapeutics Presents NORSE TWO Phase 3 Pivotal Safety and Efficacy Data for ONS-5010 / LYTENAVA™ (bevacizumab-vikg) at the Retina Subspecialty Day, American Academy of Ophthalmology (AAO) 2021 Annual Conference
- NORSE TWO showed highly statistically significant, clinically relevant results consistent with historical ophthalmic bevacizumab data - Data support planned...
Acasti Pharma Announces Annual Stock Option Grants
LAVAL, Québec, Nov. 12, 2021 (GLOBE NEWSWIRE) -- Acasti Pharma Inc. (“Acasti” or the “Company”) (Nasdaq: ACST and TSX-V: ACST),...
Vaxil Announces Change of Auditor
Not for distribution by US newswire or in United States NESS-ZIONA, Israel , Nov. 12, 2021 (GLOBE NEWSWIRE) -- VAXIL...
Psychemedics Corporation Reports Stronger Revenue, Operating Profit and Earnings Growth in Third Quarter 2021
ACTON, Mass., Nov. 12, 2021 (GLOBE NEWSWIRE) -- Psychemedics Corporation (NASDAQ:PMD), the world’s largest provider of hair testing for drugs...